ATC
ALNY icon

Argent Trust Co’s Alnylam Pharmaceuticals ALNY Stock Holding History

Argent Trust Co’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,389
Closed -$203K – 494
2022
Q2 		$203K Sell
1,389
-797
-36% -$113K 0.01% 502
2022
Q1 		$358K Sell
2,186
-71
-3% -$10.8K 0.02% 409
2021
Q4 		$383K Buy
2,257
+31
+1% +$5.76K 0.02% 414
2021
Q3 		$421K Buy
2,226
+68
+3% +$12.8K 0.03% 376
2021
Q2 		$366K Buy
2,158
+139
+7% +$20.4K 0.02% 406
2021
Q1 		$285K Buy
+2,019
New +$304K 0.02% 426

Other funds holding ALNY

Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Argent Trust Co's ALNY Position: Q3 2022 in Review

Argent Trust Co sold out of Alnylam Pharmaceuticals (ALNY) in Q3 2022, closing a stake of 1,389 shares — an estimated $203K sold.

Argent Trust Co first reported a position in ALNY in Q1 2021 and held it in 6 quarters. The position peaked at $421K in Q3 2021. 497 funds tracked by Wall St. Rank hold ALNY as of Q3 2022.

  • Argent Trust Co reported no remaining Alnylam Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Argent Trust Co sold 1,389 Alnylam Pharmaceuticals shares in Q3 2022, an estimated $203K.
  • Argent Trust Co first reported a position in Alnylam Pharmaceuticals in Q1 2021 and held it in 6 quarters.
  • Argent Trust Co's Alnylam Pharmaceuticals position peaked at $421K in Q3 2021.
  • 497 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2022.

Based on Argent Trust Co's 13F filing for Q3 2022, filed 10 Nov 2022.